We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00093028
Recruitment Status : Completed
First Posted : October 1, 2004
Last Update Posted : July 2, 2010
Sponsor:
Information provided by:
University of Arkansas

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2006
  Study Completion Date : January 2006